REFRACTORY METASTATIC COLORECTAL CANCER
Clinical trials for REFRACTORY METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for REFRACTORY METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat colorectal cancer: experimental combo enters late-stage trial
Disease control Recruiting nowThis study tests whether adding the experimental drug suvemcitug to standard chemotherapy (FTD/TPI) helps people with advanced colorectal cancer that has stopped responding to other treatments live longer. About 464 participants will receive either the combination or a placebo pl…
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New combo therapy targets liver tumors in advanced colorectal cancer
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer pills and an injection, works better than the standard pills and injection alone. It is for people with colorectal cancer that has spread mainly to the liver and is no longer …
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC